Pluri Inc. Research and Development Expense
Pluri Inc. (PLUR) reported Research and Development Expense of $15.09 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-09-10
- Pluri Inc. research and development expense for the quarter ending 2026-06-30 was $3.37M, a 15.55% decline year-over-year.
- Pluri Inc. research and development expense for the quarter ending 2026-03-31 was $3.96M, a 30.20% increase year-over-year.
- Pluri Inc. research and development expense for the quarter ending 2025-12-31 was $3.83M, a 30.80% increase year-over-year.
- Pluri Inc. research and development expense for the quarter ending 2025-09-30 was $3.93M, a 36.07% increase year-over-year.
- Pluri Inc. research and development expense for fiscal 2026 was $15.09M, a 17.44% increase from fiscal 2025.
- Pluri Inc. research and development expense for fiscal 2025 was $12.85M, a 3.25% increase from fiscal 2024.
- Pluri Inc. research and development expense for fiscal 2024 was $12.45M, a 20.95% decline from fiscal 2023.
- Pluri Inc. research and development expense for fiscal 2023 was $15.74M, a 36.01% decline from fiscal 2022.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10 | $7.33M derived: sum of 2 quarters · filed 2026-09-10 | $11.16M derived: sum of 3 quarters · filed 2026-09-10 | $15.09M 10-K · filed 2026-09-10 | ||||
| 2026-03-31 | $3.96M 10-Q · filed 2026-05-14 | $7.79M derived: sum of 2 quarters · filed 2026-05-14 | $11.72M 10-Q · filed 2026-05-14 | $15.71M derived: sum of 4 quarters · filed 2026-09-10 | ||||
| 2025-12-31 | $3.83M 10-Q · filed 2026-02-12 | $7.76M 10-Q · filed 2026-02-12 | $11.75M derived: sum of 3 quarters · filed 2026-09-10 | $14.79M derived: sum of 4 quarters · filed 2026-09-10 | ||||
| 2025-09-30 | $3.93M 10-Q · filed 2025-11-12 | $7.92M derived: sum of 2 quarters · filed 2026-09-10 | $10.97M derived: sum of 3 quarters · filed 2026-09-10 | $13.89M derived: sum of 4 quarters · filed 2026-09-10 | ||||
| 2025-06-30 | $3.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10 | $7.04M derived: sum of 2 quarters · filed 2026-09-10 | $9.96M derived: sum of 3 quarters · filed 2026-09-10 | $12.85M 10-K · filed 2026-09-10 | ||||
| 2025-03-31 | $3.04M 10-Q · filed 2026-05-14 | $5.97M derived: sum of 2 quarters · filed 2026-05-14 | $8.86M 10-Q · filed 2026-05-14 | $12.25M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | $2.92M 10-Q · filed 2026-02-12 | $5.81M 10-Q · filed 2026-02-12 | $9.21M derived: sum of 3 quarters · filed 2026-02-12 | $12.30M derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-09-30 | $2.89M 10-Q · filed 2025-11-12 | $6.28M derived: sum of 2 quarters · filed 2025-11-12 | $9.38M derived: sum of 3 quarters · filed 2025-11-12 | $12.34M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $3.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-17 | $6.49M derived: sum of 2 quarters · filed 2025-09-17 | $9.45M derived: sum of 3 quarters · filed 2025-09-17 | $12.45M 10-K · filed 2025-09-17 | ||||
| 2024-03-31 | $3.09M 10-Q · filed 2025-05-13 | $6.06M derived: sum of 2 quarters · filed 2025-05-13 | $9.05M 10-Q · filed 2025-05-13 | $12.57M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $2.96M 10-Q · filed 2025-02-11 | $5.96M 10-Q · filed 2025-02-11 | $9.48M derived: sum of 3 quarters · filed 2025-02-11 | $13.65M derived: sum of 4 quarters · filed 2025-02-11 | ||||
| 2023-09-30 | $2.99M 10-Q · filed 2024-11-12 | $3.37M 10-Q · filed 2023-11-13 | $6.51M derived: sum of 2 quarters · filed 2024-11-12 | $10.68M derived: sum of 3 quarters · filed 2024-11-12 | $14.47M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $3.52M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-18 | $7.69M derived: sum of 2 quarters · filed 2024-09-18 | $11.47M derived: sum of 3 quarters · filed 2024-09-18 | $15.74M 10-K · filed 2024-09-18 | $17.41M 10-K · filed 2023-09-12 | |||
| 2023-03-31 | $4.17M 10-Q · filed 2024-05-09 | $4.33M 10-Q · filed 2023-05-09 | $7.95M derived: sum of 2 quarters · filed 2024-05-09 | $12.22M 10-Q · filed 2024-05-09 | $13.41M 10-Q · filed 2023-05-09 | $17.86M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | $3.79M 10-Q · filed 2024-02-12 | $4.58M 10-Q · filed 2023-02-13 | $8.06M 10-Q · filed 2024-02-12 | $9.08M 10-Q · filed 2023-02-13 | $13.69M derived: sum of 3 quarters · filed 2024-02-12 | $19.96M derived: sum of 4 quarters · filed 2024-02-12 | ||
| 2022-09-30 | $4.50M 10-Q · filed 2023-11-13 | $9.90M derived: sum of 2 quarters · filed 2023-11-13 | $16.18M derived: sum of 3 quarters · filed 2023-11-13 | $22.72M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $5.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-12 | $11.67M derived: sum of 2 quarters · filed 2023-09-12 | $18.21M derived: sum of 3 quarters · filed 2023-09-12 | $24.61M 10-K · filed 2023-09-12 | ||||
| 2022-03-31 | $6.27M 10-Q · filed 2023-05-09 | $12.81M derived: sum of 2 quarters · filed 2023-05-09 | $19.20M 10-Q · filed 2023-05-09 | $27.71M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | $6.54M 10-Q · filed 2023-02-13 | $12.93M 10-Q · filed 2023-02-13 | $21.44M derived: sum of 3 quarters · filed 2023-02-13 | $29.26M derived: sum of 4 quarters · filed 2023-02-13 | ||||
| 2021-09-30 | $6.39M 10-Q · filed 2022-11-10 | $14.90M derived: sum of 2 quarters · filed 2022-11-10 | $22.72M derived: sum of 3 quarters · filed 2022-11-10 | $30.72M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $8.51M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-21 | $16.33M derived: sum of 2 quarters · filed 2022-09-21 | $24.33M derived: sum of 3 quarters · filed 2022-09-21 | $30.53M 10-K · filed 2022-09-21 | ||||
| 2021-03-31 | $7.82M 10-Q · filed 2022-05-09 | $15.82M derived: sum of 2 quarters · filed 2022-05-09 | $22.03M 10-Q · filed 2022-05-09 | $27.98M derived: sum of 4 quarters · filed 2022-05-09 | ||||
| 2020-12-31 | $8.00M 10-Q · filed 2022-02-07 | $14.20M 10-Q · filed 2022-02-07 | $20.16M derived: sum of 3 quarters · filed 2022-02-07 | $25.90M derived: sum of 4 quarters · filed 2022-02-07 | ||||
| 2020-09-30 | $6.20M 10-Q · filed 2021-11-08 | $12.16M derived: sum of 2 quarters · filed 2021-11-08 | $17.90M derived: sum of 3 quarters · filed 2021-11-08 | $23.47M derived: sum of 4 quarters · filed 2021-11-08 | ||||
| 2020-06-30 | $5.96M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-13 | $11.70M derived: sum of 2 quarters · filed 2021-09-13 | $17.27M derived: sum of 3 quarters · filed 2021-09-13 | $23.10M 10-K · filed 2021-09-13 | ||||
| 2020-03-31 | $5.74M 10-Q · filed 2021-05-06 | $11.31M derived: sum of 2 quarters · filed 2021-05-06 | $17.14M 10-Q · filed 2021-05-06 | $23.40M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | $5.57M 10-Q · filed 2021-02-08 | $11.40M 10-Q · filed 2021-02-08 | $17.66M derived: sum of 3 quarters · filed 2021-02-08 | $26.08M derived: sum of 4 quarters · filed 2021-02-08 | ||||
| 2019-09-30 | $5.83M 10-Q · filed 2020-11-05 | $12.09M derived: sum of 2 quarters · filed 2020-11-05 | $20.51M derived: sum of 3 quarters · filed 2020-11-05 | $27.94M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $6.26M derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-10 | $14.69M derived: sum of 2 quarters · filed 2020-09-10 | $22.12M derived: sum of 3 quarters · filed 2020-09-10 | $29.88M 10-K · filed 2020-09-10 | ||||
| 2019-03-31 | $8.42M 10-Q · filed 2020-05-11 | $15.85M derived: sum of 2 quarters · filed 2020-05-11 | $23.62M 10-Q · filed 2020-05-11 | $31.06M derived: sum of 4 quarters · filed 2020-09-10 | ||||
| 2018-12-31 | $7.43M 10-Q · filed 2020-02-06 | $15.20M 10-Q · filed 2020-02-06 | $22.64M derived: sum of 3 quarters · filed 2020-09-10 | $30.12M derived: sum of 4 quarters · filed 2020-09-10 | ||||
| 2018-09-30 | $7.76M 10-Q · filed 2019-11-07 | $15.20M derived: sum of 2 quarters · filed 2020-09-10 | $22.68M derived: sum of 3 quarters · filed 2020-09-10 | $28.94M derived: sum of 4 quarters · filed 2020-09-10 | ||||
| 2018-06-30 | $7.44M derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-10 | $14.92M derived: sum of 2 quarters · filed 2020-09-10 | $21.18M derived: sum of 3 quarters · filed 2020-09-10 | $26.37M 10-K · filed 2020-09-10 | ||||
| 2018-03-31 | $7.48M 10-Q · filed 2019-05-06 | $13.74M derived: sum of 2 quarters · filed 2019-05-06 | $18.93M 10-Q · filed 2019-05-06 | $24.84M derived: sum of 4 quarters · filed 2019-09-12 | ||||
| 2017-12-31 | $6.26M 10-Q · filed 2019-02-06 | $11.45M 10-Q · filed 2019-02-06 | $17.36M derived: sum of 3 quarters · filed 2019-09-12 | $23.94M derived: sum of 4 quarters · filed 2019-09-12 | ||||
| 2017-09-30 | $5.19M 10-Q · filed 2018-11-07 | $11.10M derived: sum of 2 quarters · filed 2019-09-12 | $17.68M derived: sum of 3 quarters · filed 2019-09-12 | $23.16M derived: sum of 4 quarters · filed 2019-09-12 | ||||
| 2017-06-30 | $5.91M derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-12 | $12.49M derived: sum of 2 quarters · filed 2019-09-12 | $17.97M derived: sum of 3 quarters · filed 2019-09-12 | $24.00M 10-K · filed 2019-09-12 | ||||
| 2017-03-31 | $6.58M 10-Q · filed 2018-05-09 | $12.06M derived: sum of 2 quarters · filed 2018-05-09 | $18.09M 10-Q · filed 2018-05-09 | $24.52M derived: sum of 4 quarters · filed 2018-09-12 | ||||
| 2016-12-31 | $5.48M 10-Q · filed 2018-02-06 | $11.51M 10-Q · filed 2018-02-06 | $17.94M derived: sum of 3 quarters · filed 2018-09-12 | $23.74M derived: sum of 4 quarters · filed 2018-09-12 | ||||
| 2016-09-30 | $6.03M 10-Q · filed 2017-11-07 | $12.46M derived: sum of 2 quarters · filed 2018-09-12 | $18.26M derived: sum of 3 quarters · filed 2018-09-12 | $23.83M derived: sum of 4 quarters · filed 2018-09-12 | ||||
| 2016-06-30 | $6.43M derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-12 | $12.23M derived: sum of 2 quarters · filed 2018-09-12 | $17.80M derived: sum of 3 quarters · filed 2018-09-12 | $22.86M 10-K · filed 2018-09-12 | ||||
| 2016-03-31 | $5.80M 10-Q · filed 2017-05-08 | $11.37M derived: sum of 2 quarters · filed 2017-05-08 | $16.43M 10-Q · filed 2017-05-08 | $22.54M derived: sum of 4 quarters · filed 2017-09-07 | ||||
| 2015-12-31 | $5.57M 10-Q · filed 2017-02-08 | $10.63M 10-Q · filed 2017-02-08 | $16.74M derived: sum of 3 quarters · filed 2017-09-07 | $22.93M derived: sum of 4 quarters · filed 2017-09-07 | ||||
| 2015-09-30 | $5.06M 10-Q · filed 2016-11-07 | $11.17M derived: sum of 2 quarters · filed 2017-09-07 | $17.35M derived: sum of 3 quarters · filed 2017-09-07 | $22.74M derived: sum of 4 quarters · filed 2017-09-07 | ||||
| 2015-06-30 | $6.11M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07 | $12.29M derived: sum of 2 quarters · filed 2017-09-07 | $17.68M derived: sum of 3 quarters · filed 2017-09-07 | $23.42M 10-K · filed 2017-09-07 | ||||
| 2015-03-31 | $6.18M 10-Q · filed 2016-05-09 | $11.57M derived: sum of 2 quarters · filed 2016-05-09 | $17.30M 10-Q · filed 2016-05-09 | $23.75M derived: sum of 4 quarters · filed 2016-09-07 | ||||
| 2014-12-31 | $5.38M 10-Q · filed 2016-02-08 | $11.12M 10-Q · filed 2016-02-08 | $17.57M derived: sum of 3 quarters · filed 2016-09-07 | $24.45M derived: sum of 4 quarters · filed 2016-09-07 | ||||
| 2014-09-30 | $5.74M 10-Q · filed 2015-11-05 | $12.19M derived: sum of 2 quarters · filed 2016-09-07 | $19.07M derived: sum of 3 quarters · filed 2016-09-07 | $25.18M derived: sum of 4 quarters · filed 2016-09-07 | ||||
| 2014-06-30 | $6.45M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-07 | $13.33M derived: sum of 2 quarters · filed 2016-09-07 | $19.44M derived: sum of 3 quarters · filed 2016-09-07 | $24.94M 10-K · filed 2016-09-07 | ||||
| 2014-03-31 | $6.88M 10-Q · filed 2015-05-06 | $12.99M derived: sum of 2 quarters · filed 2015-05-06 | $18.49M 10-Q · filed 2015-05-06 | $25.54M derived: sum of 4 quarters · filed 2015-09-09 | ||||
| 2013-12-31 | $6.11M 10-Q · filed 2015-02-05 | $11.60M 10-Q · filed 2015-02-05 | $18.65M derived: sum of 3 quarters · filed 2015-09-09 | $23.62M derived: sum of 4 quarters · filed 2015-09-09 | ||||
| 2013-09-30 | $5.50M 10-Q · filed 2014-11-06 | $12.54M derived: sum of 2 quarters · filed 2015-09-09 | $17.51M derived: sum of 3 quarters · filed 2015-09-09 | $21.66M derived: sum of 4 quarters · filed 2015-09-09 | ||||
| 2013-06-30 | $7.05M derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-09 | $12.01M derived: sum of 2 quarters · filed 2015-09-09 | $16.16M derived: sum of 3 quarters · filed 2015-09-09 | $19.91M 10-K · filed 2015-09-09 | ||||
| 2013-03-31 | $4.96M 10-Q · filed 2014-05-08 | $9.11M derived: sum of 2 quarters · filed 2014-05-08 | $12.86M 10-Q · filed 2014-05-08 | $16.29M derived: sum of 4 quarters · filed 2014-09-11 | ||||
| 2012-12-31 | $4.15M 10-Q · filed 2014-02-05 | $4.15K 10-Q · filed 2013-01-31 | $7.89M 10-Q · filed 2014-02-05 | $7.89K 10-Q · filed 2013-01-31 | $11.33M derived: sum of 3 quarters · filed 2014-09-11 | $14.75M derived: sum of 4 quarters · filed 2014-09-11 | ||
| 2012-09-30 | $3.75M 10-Q · filed 2013-11-05 | $7.18M derived: sum of 2 quarters · filed 2014-09-11 | $10.60M derived: sum of 3 quarters · filed 2014-09-11 | $10.60M derived: sum of 4 quarters · filed 2014-09-11 | ||||
| 2012-06-30 | $3.43M derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-11 | $6.85M derived: sum of 2 quarters · filed 2014-09-11 | $6.86M derived: sum of 3 quarters · filed 2014-09-11 | $12.69M 10-K · filed 2014-09-11 | $12.71M 10-K · filed 2012-09-10 | |||
| 2012-03-31 | $3.42M 10-Q · filed 2013-05-08 | $3.43M 10-Q · filed 2012-05-08 | $3.42M derived: sum of 2 quarters · filed 2013-05-08 | $9.25M 10-Q · filed 2013-05-08 | $9.27M 10-Q · filed 2012-05-08 | $8.77M derived: sum of 4 quarters · filed 2013-09-11 | ||
| 2011-12-31 | $2.97K 10-Q · filed 2013-01-31 | $2.98M 10-Q · filed 2012-02-09 | $5.83K 10-Q · filed 2013-01-31 | $5.84M 10-Q · filed 2012-02-09 | $5.34M derived: sum of 3 quarters · filed 2013-09-11 | $7.49M derived: sum of 4 quarters · filed 2013-09-11 | ||
| 2011-09-30 | $2.86M 10-Q · filed 2012-11-06 | $2.87M 10-Q · filed 2011-11-09 | $5.34M derived: sum of 2 quarters · filed 2013-09-11 | $7.49M derived: sum of 3 quarters · filed 2013-09-11 | $9.67M derived: sum of 4 quarters · filed 2013-09-11 | |||
| 2011-06-30 | $2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-11 | $4.62M derived: sum of 2 quarters · filed 2013-09-11 | $6.81M derived: sum of 3 quarters · filed 2013-09-11 | $8.31M 10-K · filed 2013-09-11 | ||||
| 2011-03-31 | $2.15M 10-Q · filed 2012-05-08 | $4.33M derived: sum of 2 quarters · filed 2012-05-08 | $5.83M 10-Q · filed 2012-05-08 | |||||
| 2010-12-31 | $2.19M 10-Q · filed 2012-02-09 | $3.69M 10-Q · filed 2012-02-09 | ||||||
| 2010-09-30 | $1.50M 10-Q · filed 2011-11-09 | |||||||
| 2010-06-30 | $6.12M 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |